COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer (PROJECTION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04246203
Recruitment Status : Not yet recruiting
First Posted : January 29, 2020
Last Update Posted : September 2, 2020
Hoffmann-La Roche
Information provided by (Responsible Party):
Benedikt Westphalen, Ludwig-Maximilians - University of Munich

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 1, 2022
Estimated Study Completion Date : March 1, 2025